Nynke M. Wiersma

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists-a Nationwide Linked-data Dutch Study.

Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists-a Nationwide Linked-data Dutch Study.

Journal: Thrombosis and haemostasis

Published: January 02, 2026

Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study.

Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 22, 2025

Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort study.

Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort study.

Journal: Research and practice in thrombosis and haemostasis

Published: June 12, 2025

Quality of vitamin K antagonist treatment during the last year of life.

Quality of vitamin K antagonist treatment during the last year of life.

Journal: HemaSphere

Published: November 18, 2024

Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.

Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.

Journal: Circulation

Published: August 27, 2023

Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-β2-glycoprotein I antibody titers.

Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-β2-glycoprotein I antibody titers.

Journal: Research and practice in thrombosis and haemostasis

Published: September 06, 2022

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Journal: BMJ open

Published: January 01, 2020

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study.

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 18, 2017

Anticoagulant bridging in left-sided mechanical heart valve patients.

Anticoagulant bridging in left-sided mechanical heart valve patients.

Journal: International journal of cardiology

Published: August 10, 2016

Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.

Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 14, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026